Bio-Rad Laboratories, Inc. (BIO): Price and Financial Metrics

Bio-Rad Laboratories, Inc. (BIO): $428.71

16.12 (+3.91%)

POWR Rating

Component Grades














  • Sentiment is the dimension where BIO ranks best; there it ranks ahead of 98.86% of US stocks.
  • The strongest trend for BIO is in Growth, which has been heading up over the past 177 days.
  • BIO's current lowest rank is in the Momentum metric (where it is better than 4.74% of US stocks).

BIO Stock Summary

  • BIO-RAD LABORATORIES INC's stock had its IPO on January 1, 1986, making it an older stock than 93.22% of US equities in our set.
  • With a year-over-year growth in debt of 556.34%, BIO-RAD LABORATORIES INC's debt growth rate surpasses 96.52% of about US stocks.
  • Over the past twelve months, BIO has reported earnings growth of -149.62%, putting it ahead of just 10.75% of US stocks in our set.
  • If you're looking for stocks that are quantitatively similar to BIO-RAD LABORATORIES INC, a group of peers worth examining would be PHG, UPC, VOXX, RDY, and DAKT.
  • BIO's SEC filings can be seen here. And to visit BIO-RAD LABORATORIES INC's official web site, go to

BIO Valuation Summary

  • BIO's price/sales ratio is 4.4; this is 131.58% higher than that of the median Healthcare stock.
  • BIO's EV/EBIT ratio has moved down 15 over the prior 243 months.

Below are key valuation metrics over time for BIO.

Stock Date P/S P/B P/E EV/EBIT
BIO 2022-09-23 4.4 1.4 -6.5 -5.1
BIO 2022-09-22 4.3 1.4 -6.4 -5.1
BIO 2022-09-21 4.5 1.4 -6.6 -5.2
BIO 2022-09-20 4.5 1.5 -6.7 -5.3
BIO 2022-09-19 4.6 1.5 -6.8 -5.4
BIO 2022-09-16 4.6 1.5 -6.9 -5.4

BIO Growth Metrics

    Its 5 year revenue growth rate is now at 12.68%.
  • The 5 year net income to common stockholders growth rate now stands at 1508.72%.
  • Its 3 year net income to common stockholders growth rate is now at -117.62%.
BIO's revenue has moved up $659,358,000 over the prior 52 months.

The table below shows BIO's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-06-30 2,870.979 484.8 -1,942.423
2022-03-31 2,895.811 589.226 -101.125
2021-12-31 2,922.545 656.521 4,245.902
2021-09-30 2,979.615 783.331 6,658.663
2021-06-30 2,879.829 688.632 4,045.454
2021-03-31 2,700.778 626.13 4,097.769

BIO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • BIO has a Quality Grade of B, ranking ahead of 77.91% of graded US stocks.
  • BIO's asset turnover comes in at 0.192 -- ranking 66th of 75 Measuring and Control Equipment stocks.
  • AATC, HTGM, and WAT are the stocks whose asset turnover ratios are most correlated with BIO.

The table below shows BIO's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.192 0.570 0.617
2021-06-30 0.213 0.566 0.439
2021-03-31 0.220 0.563 0.497
2020-12-31 0.233 0.565 0.520
2020-09-30 0.245 0.550 0.549
2020-06-30 0.270 0.544 0.346

BIO Price Target

For more insight on analysts targets of BIO, see our BIO price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $856.25 Average Broker Recommendation 1.25 (Strong Buy)

BIO Stock Price Chart Interactive Chart >

Price chart for BIO

BIO Price/Volume Stats

Current price $428.71 52-week high $798.97
Prev. close $412.59 52-week low $406.24
Day low $414.66 Volume 187,100
Day high $431.99 Avg. volume 196,558
50-day MA $501.13 Dividend yield N/A
200-day MA $555.80 Market Cap 12.73B

Bio-Rad Laboratories, Inc. (BIO) Company Bio

Bio-Rad Laboratories manufactures and supplies products and systems used to separate complex chemical and biological materials, as well as to identify, analyze, and purify their components for life science research, healthcare, analytical chemistry, and other markets. The company operates through two segments, Life Science and Clinical Diagnostics. The company was founded in 1952 and is based in Hercules, California.

BIO Latest News Stream

Event/Time News Detail
Loading, please wait...

BIO Latest Social Stream

Loading social stream, please wait...

View Full BIO Social Stream

Latest BIO News From Around the Web

Below are the latest news stories about BIO-RAD LABORATORIES INC that investors may wish to consider to help them evaluate BIO as an investment opportunity.

Patterson Companies (PDCO) Q1 Earnings & Sales Miss Estimates

Patterson Companies' (PDCO) fiscal first-quarter 2023 results were adversely impacted by unfavorable currency movements.

Yahoo | September 1, 2022

Cooper Companies (COO) Q3 Earnings & Revenues Top Estimates

Despite a decline in the bottom line, Cooper Companies' (COO) fiscal third-quarter earnings reflect solid segmental performance.

Yahoo | September 1, 2022

What's in Store for Patterson Companies (PDCO) in Q1 Earnings?

Patterson Companies' (PDCO) fiscal first-quarter results are likely to reflect an improvement at the Animal Health segment.

Yahoo | August 29, 2022

Cooper Companies (COO) to Post Q3 Earnings: What's in Store?

Cooper Companies' (COO) fiscal third-quarter results are likely to reflect segmental strength.

Yahoo | August 25, 2022

Here's Why You Should Invest in Bio-Rad (BIO) Stock Now

Investors are optimistic about Bio-Rad's (BIO) better-than-expected results and continued growth across major geographies.

Yahoo | August 22, 2022

Read More 'BIO' Stories Here

BIO Price Returns

1-mo -11.33%
3-mo -14.66%
6-mo -24.90%
1-year -42.78%
3-year 28.84%
5-year 92.92%
YTD -43.26%
2021 29.61%
2020 57.54%
2019 59.34%
2018 -2.70%
2017 30.94%

Continue Researching BIO

Want to see what other sources are saying about Bio-Rad Laboratories Inc's financials and stock price? Try the links below:

Bio-Rad Laboratories Inc (BIO) Stock Price | Nasdaq
Bio-Rad Laboratories Inc (BIO) Stock Quote, History and News - Yahoo Finance
Bio-Rad Laboratories Inc (BIO) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.5512 seconds.